Parameter (unit) normoalbuminuria (n = 27) microalbuminuria (n = 104) proteinuria (n = 130) ESRD (n = 48) P
Age (years) 66 [61 - 72] 68 [57 - 77] 66 [58 - 75] 69 [64 - 75] 0.179
Duration of diabetes (years) 14 [10 - 22] 8 [5 - 14] 14.5 [8 - 20] 17 [12 - 22] <0.001
FPG (mmol/l) 7.7 [6.2 - 10.2] 7.9 [7.3 - 10.5] 9.3 [7.5 - 11.3] 7.8 [6.3 - 11] 0.173
HbA1C (%) 6.4 [5.2 - 7.5] 6.45 [5.35 - 8.1] 8.1 [6 - 9.6] 6.2 [5.2 - 7.8] 0.062
Total cholesterol (mmol/l) 4.9 [4.3 - 6.3] 4.9 [4.3 - 5.7] 5.2 [4.3 - 6.2] 4.8 [3.9 - 5.5] 0.323
Triglycerides(mmol/l) 1.88 [1.32 - 2.97] 2 [1.32 - 2.71] 2.15 [1.52 - 3.52] 2.11 [1.62 - 3.11] 0.027
Creatinin (µmol/l) 90 [83 - 110] 114 [92 - 147] 139 [104 - 175] 420 [250 - 550] <0.001
Proteinuria (g/24h) 0.11 [0.08 - 0.13] 0.14 [0.08 - 0.22] 1.33 [0.4 - 3.06] - <0.001
GFR (ml/min per 1.73m2) 1.62 [1.32 - 2.3] 1.1 [0.7 - 1.6] 0.88 [0.71 - 1.38] - <0.001
UAE (mg/24h) 10 [8 - 18] 50 [21 - 160] 181 [97 - 545] - <0.001
Data are expressed as median [interquartile range]. Comparisons were made by Kruskal-Wallis ANOVA.
Abbreviations: ESRD, end-stage renal disease; FPG, fasting plasma glucose; GFR, glomerular filtration rate; UAE, urinary albumin excretion.
Table 1: Clinical characteristics of the study participants.